ABSTRACT We used intracellular recording in the hippocampal slice in vitro to characterize further the mechanisms behind the unusual excitatory action of opiates and opioid peptides on hippocampal pyramidal cells in vivo. No significant effect on resting membrane potential, input resistance, or action potential size in cortical area 1 (CAI) pyramidal cells was observed with morphine sulfate, ,f-endorphin, [Met5]enkephalin, or Leu5]enkephalin at 1-50 ,LM. However, in all cells studied, these agents markedly reduced the size of inhibitory postsynaptic potentials generated by stimulation of the stratum radiatum or alveus. Excitatory postsynaptic potentials were also diminished in many of these cells. The effects of the opioids were antagonized by naloxone. These results are consistent with excitation of pyramidal neurons by a disinhibitory mechanism.
The discovery of opioid.peptides has provoked considerable interest in their possible function. The most common action of exogenous opiates and opioid peptides is naloxone-sensitive inhibition of neuronal activity (1, 2) . However, several studies have shown naloxone-sensitive excitation with iontophoresis of opioids onto hippocampal pyramidal cells (3) (4) (5) . The hippocampus also exhibits epileptiform activity with opioid peptide administration (6, 7) . On the basis ofextracellular studies on the in vivo hippocampus (4, 8) , it was suggested that the pyramidal cell may be activated by the opiates indirectly through a disinhibitory mechanism-by depression ofthe firing ofinhibitory interneurons. Results of more recent extracellular studies (9) (10) (11) (12) (13) (14) of the hippocampus in vivo and in vitro have generally corroborated this view.
However, recent reports of intracellular studies on hippocampal pyramidal neurons in vitro reveal several inconsistencies. Thus, Deadwyler and Robinson (15) have found direct effects ofhigh concentrations (1 mM) ofmorphine on membrane potentials of neurons in the hippocampal slice. Still, by virtue of the ability of pentabarbital to antagonize these potential changes, these authors suggest that a disinhibitorv mechanism is likely to account for this action (14) . Recent studies on the same preparation from three other laboratories (16) (17) (18) have revealed no effect of lower doses of the opiate peptides on resting membrane properties. However, whereas Haas and Ryall (16) and Dingledine (17) found that opioids enhance excitatory postsynaptic potentials (EPSPs) with no change in inhibitory postsynaptic potential (IPSP) size, Nicoll et aL (18) showed a dramatic reduction of both recurrent and feedforward IPSPs. In contrast, Gahwiler (19) reported that perfusion of opioids onto hippocampal pyramidal cells in culture has no effect on resting membrane properties but enlarges spontaneous EPSPs and reduces evoked IPSPs, leading to paroxysmal depolarization shifts.
The reason for these discrepancies is unknown, although they may arise from the complicated feedback circuitry of the hippocampus and the close interrelationship between excitatory and inhibitory mechanisms in the pyramidal cell. Thus, it is difficult to explain how opiates might elevate EPSP size in the pyramidal cell without concomitant increases in IPSPs. To help clarify these discrepancies, we pursued ongoing studies of the action of opioids on both EPSPs and IPSPs in the same pyramidal cells of the hippocampal slice preparation (20, 21) . METHODS Male albino rats of 130-to 200-g body weight were decapitated, and hippocampal formations were rapidly removed. Transverse hippocampal slices of 360-to 400-,um thickness were cut on a Sorval brain slicer and immediately placed in cold (6-100C; gassed with 95% 02/5% CO2) 124 mM NaCV3.3 mM KCV 1.25 mM KH2PO42.4 mM MgSO4.7H2O/2.5 mM CaCl2/ 25.7 mM NaHCOJ10.0 mM glucose. This standard solution henceforth will be referred to as "CSF." The slices were then transferred and incubated in a chamber for 1 hr in CSF that was continuously perfused at 0.5-2 ml/min and gradually warmed from 31°C to 35°C. Field potentials in response to stimulation of the stratum radiatum or the alveus were recorded in cortical area 1 (CA1) with an extracellular pipette (1 MW, 3 M NaCl) (Fig. LA) . Slices with population spikes less than 3 mV (Fig. 1B The apparent lack of an EPSP may be due to the shunting effect of the IPSP, perhaps indicating a feedforward inhibitory mechanism (22) . (E) Current-voltage curve generated by intracellular injection of constant-current, square-wave pulses of incrementally increasing intensity (roughly 0.15, 0.33, and 0.48 nA), through a bridge circuit and the recording electrode. *, CSF control; X, during 10 pM 3-endorphin perfusion; m, 30-min CSF washout; RMP, resting membrane potential. (Inset) Superimposed voltage pulses generated by such current before 3-endorphin perfusion. Note the time-dependent rectification of the hyperpolarizing pulses always seen in hippocampal pyramidal neurons; neither the fast-changing nor the flat portions of the pulsewere altered by the peptide. Current-voltage plot was measured from the flat portion; thus, input resistance is not changed.
Calibration pulse at the beginning of the Inset record was ( Fig. 1D) . These IPSPs were 3-7 mV in amplitude and appear identical in form to those described elsewhere (18, 23, 25) .
Perfusion of the slices with /3-endorphin (1-10 AM) reduced the peak size of the IPSPs (Fig. 3 A and B (Fig. 3A) by concomitant perfusion of naloxone at doses (10-20 ,utM) that had little or no effect on IPSPs or membrane properties.
In many of the same neurons the EPSPs also seemed to be sensitive to the opiates and peptides, although reproducibly stable EPSPs without spikes were difficult to obtain. Whether recorded at resting potential or superimposed on hyperpolarizing pulses to prevent spike generation (Fig. 3C) (20 ,uM) In contrast, the opioids do appear to alter synaptic potentials. The most striking of these effects in our study is the clear reduction in the size of the IPSPs evoked by stratum radiatum stimulation. Such a reduction of inhibition in vivo would favor excitatory mechanisms, perhaps even culminating in epileptiform activity (6, 7, 15, 19) . The involvement of such a disinhibition (4, 8) is generally supported by unit and field recordings of pyramidal cells and interneurons in the hippocampus slice (9, (11) (12) (13) (14) . In this regard, our data are most in accord with the recent intracellular results of Nicoll et al. (18) and GAhwiler (19) who observed opioid-induced diminutions in IPSP size in hippocampal pyramidal cells. However, GAhwiler (19) also observed a concomitant increase in EPSP size in hippocampal cultures; Nicoll et al. (18) did not report effects of opioids on EPSPs in the slice preparation. Our results are in strongest contrast to those of Haas and Ryall (16) and Dingledine (17) who report opioid-induced augmentation of EPSPs without effect on IPSPs. Although the reason for these discrepancies is not known, we speculate that differences in methods of measuring EPSPs (e.g., with vs. without spike generation) or in methodologies of drug perfusion (e.g., with the upper surface of the slice submerged or exposed) could be responsible.
The reduction of EPSPs often seen in the present study with perfusion ofthe opioids parallels the findings ofZieglgansberger and coworkers (26, 27) and may suggest a mechanism by which the IPSPs are reduced. It is likely that the pyramidal cells activate inhibitory interneurons by releasing the same excitatory transmitter as that with which they activate each other (25) . There is good evidence that this transmitter is glutamate (see 28) . The opioids may antagonize a glutamate-induced postsynaptic activation of Na-channels in the inhibitory interneurons, as suggested for spinal neurons (26) (27) (28) (29) , although a presynaptic blockade of transmitter release (30) (31) (32) (33) or hyperpolarization of the inhibitory interneuron cannot be ruled out by the present studies. A similar action at synapses between one pyramidal cell and another would account for our frequent observation of opioid-induced reduction in EPSPs. Although it is possible that some proportion of the presumed EPSPs were contaminated by depolarizing feedforward IPSPs (22) sensitive to the opioid agonists (18) , our preliminary studies show that [DAla2, DLeu5]enkephalin also frequently antagonizes the depolarizing actions of glutamate on the hippocampal pyramidal cell.
The occasional changes in firing rate produced by the opioids (and small membrane potential changes sometimes associated with these) may be a reflection of the changes in IPSPs and EPSPs. Thus, the direction of change in firing rate for a given cell may be dependent on the synaptic drive to that cell and the Neurobiology: Siggins and (19, 23) . These shifts may represent an in vitro intracellular correlate of the interictal episodes produced by /-endorphin in vivo (6, 7) and in oculo (34) . Evidence is accumulating (35) that these epileptiform episodes, like the unit excitations evoked by iontophoretically applied opioids (3) (4) (5) , are also produced by a disinhibition of pyramidal cells. These electrographic phenomena may represent only pathological or pharmacological curiosities, or they may-signify some physiological role of the opioid peptides in hippocampal function. Recent immunohistochemical studies of hippocampus have demonstrated enkephalin-like substances in structures resembling nerve fibers, especially in regio inferior of hippocampus, but also to a lesser degree in CA1 (36) (37) (38) . However, ultrastructural elucidation of the target cell(s) for these enkephalincontaining fibers will be required to support a disinhibitory function for the endogenous peptides in hippocampus.
